Low quality sentence examples
Potem ko so vsi bolniki, ki so prejemali lumakaftor/ivakaftor(lumakaftor 400 mg/ivakaftor 250 mg na 12 ur) v preskušanju 1 ali preskušanju 2, opravili pregled v 24. tednu v preskušanju 3(do 48 tednov zdravljenja), so izvedli ad hoc analizo učinkovitosti.
An ad hoc efficacy analysis was performed after all patients who had received lumacaftor/ivacaftor(lumacaftor 400 mg/ivacaftor 250 mg q12h) in Trial 1 or Trial 2 had completed the Week 24 Visit in Trial 3(up to 48 weeks of treatment.Vsebuje zdravilni učinkovini lumakaftor in ivakaftor.
Orkambi contains the active substances lumacaftor and ivacaftor.Zdravilni učinkovini sta lumakaftor in ivakaftor.
The active substances are lumacaftor and ivacaftor.Lumakaftor in ivakaftor.
Lumacaftor and ivacaftor.Lumakaftor je močan spodbujevalec CYP3A.
Lumacaftor is a strong inducer of CYP3A.Ni znano, ali se lumakaftor ali ivakaftor izloča v materino mleko.
It is unknown if lumacaftor or ivacaftor are found in human milk.Lumakaftor in ivakaftor sta zaviralca BCRP.
Lumacaftor and ivacaftor are inhibitors of BCRP.LUM= lumakaftor; IVA= ivakaftor.
LUM= lumacaftor; IVA= ivacaftor.Ni znano, ali se lumakaftor in/ali ivakaftor
It is unknown whether lumacaftor and/or ivacaftorŠtudije in vitro kažejo, da je lumakaftor substrat beljakovine odpornosti proti raku dojke(BCRP.
In vitro studies indicate that lumacaftor is a substrate of Breast Cancer Resistance Protein(BCRP.Lumakaftor zavira prenašalca organskih anionov(OAT)
Lumacaftor inhibits the organic anion transporter(OAT)Študije in vitro so pokazale, da ima lumakaftor potencial tako za zaviranje
In vitro studies indicated that lumacaftor has the potential to both inhibitZdravilo Orkambi vsebuje dve zdravilni učinkovini, lumakaftor in ivakaftor, ki skupaj izboljšata funkcijo nenormalne beljakovine CFTR.
Orkambi contains two active substances, lumacaftor and ivacaftor that work together to improve the function of the abnormal CFTR protein.Lumakaftor je v približno 99% vezan na plazemske beljakovine,
Lumacaftor is approximately 99% bound to plasma proteins,Rezultati kažejo, da ni klinično pomembne razlike v farmakokinetičnih parametrih za lumakaftor ali ivakaftor med moškimi in ženskami.
Results indicate no clinically relevant difference in pharmacokinetic parameters for lumacaftor or ivacaftor between males and females.Natančni mehanizmi, s katerimi lumakaftor izboljša celično procesiranje
The exact mechanisms by which lumacaftor improves cellular processingPoskusi in vitro kažejo, da je lumakaftor substrat beljakovine odpornosti pri raku dojke(Breast Cancer Resistance Protein- BCRP.
In vitro experiments show that lumacaftor is a substrate for Breast Cancer Resistance Protein(BCRP.Lumakaftor ni vplival na indekse plodnosti
Lumacaftor had no effects on fertilityLumakaftor je močan spodbujevalec CYP3A,
Lumacaftor is a strong inducer of CYP3ALumakaftor in ivakaftor nista zaviralca OATP1B1,
Lumacaftor and ivacaftor are not inhibitors of OATP1B1,
